Scientists hail bottom-up design as the ‘souped-up car’ of proteins
UK researchers have created “designer” amino acids which they say will allow them to build custom biologics from the ground up and avoid the pitfalls of recombinant expression.
Archives for September 23, 2014
Two more biotechs for GSK and venture capital portfolio
GSK and venture capitalists Avalon have launched two early-stage R&D biotechs in San Diego, California.
Emergent scales up manufacturing of anthrax vaccine
Emergent BioSolutions has initiated a non-clinical study to demonstrate it can scale-up production of its anthrax vaccine, BioThrax, without making it less effective.
Mega deals like Merck-Sigma cut biopharma bargaining power says leading CMO
Life science sector consolidation is a concern for some biomanufacturers, who say mega mergers like Merck KGaA’s $17bn acquisition of Sigma-Aldrich will limit their ability to negotiate on prices.